Skip to main content
Top
Published in: Annals of Surgical Oncology 9/2017

01-09-2017 | Hepatobiliary Tumors

Positive Margins After Resection of Metastatic Colorectal Cancer in the Liver: Back to the Drawing Board?

Author: M. I. D’Angelica, MD, FACS

Published in: Annals of Surgical Oncology | Issue 9/2017

Login to get access

Excerpt

The debate over the relevance of surgical margins in patients undergoing hepatic resection for metastatic colorectal cancer has gone on for decades. For many years a “1-cm margin” rule was recommended. Based on limited and now outdated information, patients with margins closer than 1 cm appeared to have significantly worse survival. As recently as 10 years ago, our group continued to find better outcomes associated with margins greater than 1 cm.1 More recently, most studies have found that beyond a 1-mm margin, there is no associated prolongation of survival. In fact, some groups have found that a positive margin does not matter at all, although these are typically reported in series where the margin positivity rate is as high as 50%.2 To add more fuel to the fire, we recently found that compared to a true positive margin (malignant cells at the actual margin), even negative margins <1 mm were associated with improved survival.3 One thing, however, is common throughout these myriad studies: in the context of multiple tumors, they all reported the surgical margin as that of the tumor with the closest margin. …
Literature
1.
go back to reference Are C, Gonen M, Zazzali K, DeMatteo RP, Jarnagin WR, Fong Y, Blumgart LH, D’Angelica M. The impact of margins on outcome after hepatic resection for colorectal metastases. Ann Surg. 2007;140(5):756–63. Are C, Gonen M, Zazzali K, DeMatteo RP, Jarnagin WR, Fong Y, Blumgart LH, D’Angelica M. The impact of margins on outcome after hepatic resection for colorectal metastases. Ann Surg. 2007;140(5):756–63.
2.
go back to reference De Haas RJ, Wicherts DA, Flores E, Azoulay D, Castaing D, Adam R. R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery? Ann Surg. 2008;248(4):626–37.PubMed De Haas RJ, Wicherts DA, Flores E, Azoulay D, Castaing D, Adam R. R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery? Ann Surg. 2008;248(4):626–37.PubMed
3.
go back to reference Sadot E, Groot Koerkamp B, Leal JN, Shia J, Gonen M, Allen PJ, DeMatteo RP, Kingham TP, Kemeny N, Blumgart LH, Jarnagin WR, D’Angelica MI. Resection margin and survival in 2368 patients undergoing hepatic resection for metastatic colorectal cancer: surgical technique or biological surrogate? Ann Surg. 2015;262(3):476–85.CrossRefPubMedPubMedCentral Sadot E, Groot Koerkamp B, Leal JN, Shia J, Gonen M, Allen PJ, DeMatteo RP, Kingham TP, Kemeny N, Blumgart LH, Jarnagin WR, D’Angelica MI. Resection margin and survival in 2368 patients undergoing hepatic resection for metastatic colorectal cancer: surgical technique or biological surrogate? Ann Surg. 2015;262(3):476–85.CrossRefPubMedPubMedCentral
4.
go back to reference Nielsen K, Rolff HC, Eefsen RL, et al. The morphological growth patterns of colorectal liver metastases are prognostic for overall survival. Mod Pathol. 2014;27:1641–48.CrossRefPubMed Nielsen K, Rolff HC, Eefsen RL, et al. The morphological growth patterns of colorectal liver metastases are prognostic for overall survival. Mod Pathol. 2014;27:1641–48.CrossRefPubMed
5.
go back to reference Brunner SM, Kesselring R, Rubner C, et al. Prognosis according to histochemical analysis of liver metastases removed at liver resection. Br J Surg. 2014;101:1681–91.CrossRefPubMed Brunner SM, Kesselring R, Rubner C, et al. Prognosis according to histochemical analysis of liver metastases removed at liver resection. Br J Surg. 2014;101:1681–91.CrossRefPubMed
Metadata
Title
Positive Margins After Resection of Metastatic Colorectal Cancer in the Liver: Back to the Drawing Board?
Author
M. I. D’Angelica, MD, FACS
Publication date
01-09-2017
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 9/2017
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-017-5908-1

Other articles of this Issue 9/2017

Annals of Surgical Oncology 9/2017 Go to the issue